| Fri, 23 Aug 2019 13:47:06: | Should J&J owe billions for Oklahoma's opioid crisis? We'll find out Monday
|
| Fri, 23 Aug 2019 13:38:56: | Not so fast, Endo and Allergan: Ohio's AG is looking past your opioid deals
|
| Fri, 23 Aug 2019 13:36:05: | Amgen-Alexion deal rumors resurface, to the delight of investors and analysts
|
| Thu, 22 Aug 2019 15:07:20: | Pfizer, Astellas rocket toward broader Xtandi use with FDA 'priority' tag
|
| Thu, 22 Aug 2019 15:00:13: | Philippines officials nix Sanofi's attempt to bring Dengvaxia back to market
|
| Thu, 22 Aug 2019 14:00:29: | AstraZeneca and FibroGen's roxadustat, not yet filed in U.S., nabs 2nd anemia nod in China
|
| Thu, 22 Aug 2019 13:43:37: | Dillon, who shaped NICE into an influential gatekeeper, ready to exit CEO post
|
| Thu, 22 Aug 2019 13:31:04: | Enough hubbub about HHS' Truvada patents, Gilead says. We're challenging them at the PTO
|
| Thu, 22 Aug 2019 13:10:08: | Appeal shows Trump's HHS isn't giving up on putting drug prices in TV ads
|
| Thu, 22 Aug 2019 13:06:48: | Neopharma snaps up Lupin's sterile injectables business in Japan
|
| Thu, 22 Aug 2019 03:13:30: | Endo recruits former star QB John Elway for Dupuytren's contracture awareness effort
|
| Wed, 21 Aug 2019 15:02:12: | AstraZeneca's Imfinzi-tremelimumab duo flops another late-stage lung cancer trial
|
| Wed, 21 Aug 2019 14:54:06: | What's the definition of insanity? Dr. Reddy's knocked by the FDA for the 5th time this year
|
| Wed, 21 Aug 2019 14:20:36: | When it comes to cancer drug deals, one hot protein family is raking in billions: report
|
| Wed, 21 Aug 2019 14:09:43: | Roche's Hemlibra scores funding to treat much larger group of patients in England
|
| Wed, 21 Aug 2019 13:38:15: | Endo's $10M opioid deal could help other drugmakers 'out of the woods': analysts
|
| Tue, 20 Aug 2019 20:34:21: | Could a 'creative deal' between Perrigo, Amneal help reinvent both struggling businesses?
|
| Tue, 20 Aug 2019 18:11:49: | Here's an SEC lesson, courtesy TherapeuticsMD: Don't tell secrets to analysts
|
| Tue, 20 Aug 2019 18:07:29: | Pfizer adds $500M to gene therapy manufacturing plant where it will hire 300 workers
|
| Tue, 20 Aug 2019 14:41:15: | Hikma picks up Insys naloxone spray, equipment in $12M bankruptcy buy
|
| Tue, 20 Aug 2019 14:01:41: | AstraZeneca's Farxiga pads its case for new heart-helping approval
|
| Tue, 20 Aug 2019 13:18:37: | Endo strikes $10M opioid settlement with just 2 Ohio counties, and Allergan may not be far behind
|
| Mon, 19 Aug 2019 19:14:27: | WuXi builds revenues, capacity as competition boils among Asian CDMOs
|
| Mon, 19 Aug 2019 16:36:02: | Nabriva scores its first FDA nod with novel antibiotic Xenleta
|
| Mon, 19 Aug 2019 15:23:22: | AbbVie's Rinvoq label portends safety warnings for future JAKs—including Gilead's
|
